TapewireFind a company

person · Reporting owner

Donnini David

Disclosed activity across 2 companies

Tapewire entity
39195
SEC CIK
0001309092

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Sotera Health CoSHC · Entity 3869DirectorMay 24, 2024May 29, 2024
Vivid Seats Inc.SEAT · Entity 7035DirectorJune 09, 2026June 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Sotera Health Co

Report date May 24, 2024 · Filed May 29, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivativeDirect61,649 Reported balance After 2024-05-24 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2024-05-24 · Grant · Acquired 20,089 · Balance 61,649

F1: These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2: These securities consist of 20,089 RSUs and 41,560 shares of Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2: These securities consist of 20,089 RSUs and 41,560 shares of Common Stock.

Vivid Seats Inc.

Report date June 09, 2026 · Filed June 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect19,488 Reported balance After 2026-06-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-09 · Grant · Acquired 19,488 · Balance 19,488

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2: The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2: The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 09, 2026 Filed Jun 11, 2026 20:15 UTC Vivid Seats Inc. SEAT · Entity 7035 GrantRestricted Stock Units · Derivative 19,488 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-267564 · ownership.xml · derivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,488

Underlying: Class A Common Stock · 19,488 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:15 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 6,579 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-259598 · ownership.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,579 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The RSUs vested in full on June 3, 2026 (the earlier of (i) June 3, 2026 and (ii) one day prior to the Company's 2026 Annual Meeting of Stockholders). The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vested in full on June 3, 2026 (the earlier of (i) June 3, 2026 and (ii) one day prior to the Company's 2026 Annual Meeting of Stockholders). The RSUs do not have an expiration date.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:15 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 6,579 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-259598 · ownership.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

Read SEC document
October 19, 2025 Filed Oct 21, 2025 20:15 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 245 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-245138 · ownership.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245

Underlying: Class A Common Stock · 245 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The RSUs began vesting in five equal annual installments on October 19, 2022, such that they will be fully vested on October 19, 2026. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs began vesting in five equal annual installments on October 19, 2022, such that they will be fully vested on October 19, 2026. The RSUs do not have an expiration date.

Read SEC document
October 19, 2025 Filed Oct 21, 2025 20:15 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 245 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-245138 · ownership.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,831

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 22:18 UTC Vivid Seats Inc. SEAT · Entity 7035 GrantRestricted Stock Units · Derivative 131,578 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-081826 · ownership.xml · derivative · entry 3

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,578

Underlying: Class A Common Stock · 131,578 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F3 · derivative.exercise_date: The RSUs vest in full on the earlier of (i) June 3, 2026 and (ii) one day prior to the Company's 2026 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

F3 · derivative.expiration_date: The RSUs vest in full on the earlier of (i) June 3, 2026 and (ii) one day prior to the Company's 2026 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 22:18 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 38,167 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-081826 · ownership.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 38,167 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The RSUs vested in full on June 2, 2025 (the earlier of (i) June 4, 2025 and (ii) one day prior to the Company's 2025 Annual Meeting of Stockholders). The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vested in full on June 2, 2025 (the earlier of (i) June 4, 2025 and (ii) one day prior to the Company's 2025 Annual Meeting of Stockholders). The RSUs do not have an expiration date.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 22:18 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 38,167 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-081826 · ownership.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

Read SEC document
October 19, 2024 Filed Oct 22, 2024 22:16 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 4,889 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-116384 · ownership.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,779

Underlying: Class A Common Stock · 4,889 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The RSUs vest in five equal annual installments, beginning on October 19, 2022, such that they will be fully vested on October 19, 2026. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vest in five equal annual installments, beginning on October 19, 2022, such that they will be fully vested on October 19, 2026. The RSUs do not have an expiration date.

Read SEC document
October 19, 2024 Filed Oct 22, 2024 22:16 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 4,889 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-116384 · ownership.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 21:34 UTC Vivid Seats Inc. SEAT · Entity 7035 GrantRestricted Stock Units · Derivative 38,167 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-069447 · ownership.xml · derivative · entry 3

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,167

Underlying: Class A Common Stock · 38,167 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.

F3 · derivative.exercise_date: The RSUs vest in full on the earlier of (i) June 4, 2025 and (ii) one day prior to the Company's 2025 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

F3 · derivative.expiration_date: The RSUs vest in full on the earlier of (i) June 4, 2025 and (ii) one day prior to the Company's 2025 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 21:34 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 20,833 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-069447 · ownership.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 20,833 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.

F2 · derivative.exercise_date: The RSUs vest in full on the earlier of (i) June 6, 2024 and (ii) one day prior to the Company's 2024 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vest in full on the earlier of (i) June 6, 2024 and (ii) one day prior to the Company's 2024 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 21:34 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 20,833 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-069447 · ownership.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.

Read SEC document
May 24, 2024 Filed May 29, 2024 20:34 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 20,089 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065991 · ownership.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,649

F1 · shares: These securities consist of 20,089 Restricted Stock Units ("RSUs") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2 · balance_after: These securities consist of 20,089 RSUs and 41,560 shares of Common Stock.

Read SEC document
October 19, 2023 Filed Oct 23, 2023 20:23 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 4,889 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-053332 · doc4.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,668

Underlying: Class A Common Stock · 4,889 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.

F2 · derivative.exercise_date: The RSUs vest in five equal annual installments beginning on October 19, 2022, subject to the Reporting Person's continued employment or service through the applicable vesting date, such that the RSUs will be fully vested on October 19, 2026. The RSUs do not have an expiration date.

F2 · derivative.expiration_date: The RSUs vest in five equal annual installments beginning on October 19, 2022, subject to the Reporting Person's continued employment or service through the applicable vesting date, such that the RSUs will be fully vested on October 19, 2026. The RSUs do not have an expiration date.

Read SEC document
October 19, 2023 Filed Oct 23, 2023 20:23 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 4,889 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-053332 · doc4.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 21:41 UTC Vivid Seats Inc. SEAT · Entity 7035 GrantRestricted Stock Units · Derivative 20,833 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035188 · doc4.xml · derivative · entry 3

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,833

Underlying: Class A Common Stock · 20,833 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock

F3 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 6, 2024 and (ii) one day prior to the Company's 2024 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.

F3 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 6, 2024 and (ii) one day prior to the Company's 2024 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:41 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 18,079 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035188 · doc4.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 18,079 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 7, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 7, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:41 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 18,079 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035188 · doc4.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,968

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 26, 2023 Filed May 31, 2023 21:02 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share (Common Stock) 15,712 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033129 · doc4.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,560

F1 · shares: These securities consist of 15,712 Restricted Stock Units ("RSUs") that were granted on May 26, 2023, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2 · balance_after: These securities consist of 15,712 RSUs and 25,848 shares of Common Stock.

Read SEC document
October 19, 2022 Filed Oct 21, 2022 23:45 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionRestricted Stock Units · Derivative 4,889 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-054335 · doc4.xml · derivative · entry 2

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,557

Underlying: Class A Common Stock · 4,889 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock

F2 · derivative.exercise_date: The restricted stock units will vest in five equal annual installments beginning on October 19, 2022, subject to the Reporting Person's continued employment or service through the applicable vesting date.

F2 · derivative.expiration_date: The restricted stock units will vest in five equal annual installments beginning on October 19, 2022, subject to the Reporting Person's continued employment or service through the applicable vesting date.

Read SEC document
October 19, 2022 Filed Oct 21, 2022 23:45 UTC Vivid Seats Inc. SEAT · Entity 7035 Exercise / conversionClass A Common Stock 4,889 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-054335 · doc4.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock

Read SEC document
June 07, 2022 Filed Jun 9, 2022 20:30 UTC Vivid Seats Inc. SEAT · Entity 7035 GrantRestricted Stock Units · Derivative 18,079 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035403 · doc4.xml · derivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,079

Underlying: Class A Common Stock · 18,079 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 7, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 7, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.

Read SEC document
May 27, 2022 Filed Jun 1, 2022 14:18 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 10,643 $0.00 $0.00
Disclosure

SEC source: 0001822479-22-000050 · wf-form4_165409312171312.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,848

F1 · shares: These securities consist of 10,643 Restricted Stock Units ("RSUs") that were granted on May 27, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2 · balance_after: These securities consist of 10,643 RSUs and 15,205 shares of Common Stock.

Read SEC document
October 19, 2021 Filed Oct 22, 2021 01:38 UTC Vivid Seats Inc. SEAT · Entity 7035 GrantRestricted Stock Unit · Derivative 24,446 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-041124 · doc4.xml · derivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,446

Underlying: Class A Common Stock · 24,446 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The restricted stock units will vest in five equal annual installments beginning on October 19, 2022, subject to the Reporting Person's continued employment or service through the applicable vesting date.

F2 · derivative.expiration_date: The restricted stock units will vest in five equal annual installments beginning on October 19, 2022, subject to the Reporting Person's continued employment or service through the applicable vesting date.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 22:54 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 9,336 $0.00 $0.00
Disclosure

SEC source: 0001822479-21-000038 · wf-form4_162258804936480.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,205

F1 · shares: These securities consist of 9,336 Restricted Stock Units ("RSUs") that were granted on May 28, 2021, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

F2 · balance_after: These securities consist of 9,336 RSUs and 5,869 shares of Common Stock.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:53 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 5,869 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032072 · doc4.xml · nonDerivative · entry 1

Donnini David · CIK 0001309092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,869

F1 · shares: These securities consist of 5,869 Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.